Can roridin A and related macrocyclic trichothecenes inhibit protein synthesis and drive oxidative stress and inflammation that produce systemic symptoms?

Macrocyclic trichothecenes, such as roridin A, are potent mycotoxins often associated with fungi like Stachybotrys chartarum. These compounds are recognized for their ability to disrupt fundamental cellular processes, leading to broad physiological consequences.

Protein synthesis inhibition

Roridin A is a highly effective inhibitor of eukaryotic translation. It specifically targets the 60S ribosomal subunit in human cells, causing what is known as a ribotoxic stress response (RSR).

• Molecular mechanism: Roridin A damages the alpha-sarcin/ricin loop of the 28S rRNA. This region is critical for ribosome function; when damaged, ribosomes stall during the translation elongation phase.
• Cellular impact: This inhibition has been observed across various human cell types, including dermal fibroblasts, keratinocytes, and hepatocytes. The stalling of ribosomes acts as a primary cellular trigger, shifting the cell from normal protein production to a state of severe stress.

Oxidative stress and inflammatory signaling

The disruption of the ribosome initiates a cascade of downstream signaling pathways that promote inflammation and cellular damage.

• Kinase activation: Ribosome stalling activates stress-activated protein kinases (SAPKs), specifically JNK1 and p38 MAPK. This signaling is mediated by the sensor ZAKα.
• Reactive Oxygen Species (ROS): Macrocyclic trichothecenes induce the elevation of ROS and trigger endoplasmic reticulum (ER) stress. In related compounds like roridin E, these effects are directly mitigated by ROS scavengers, confirming the role of oxidative stress in their toxicity.
• Pro-inflammatory mediators: This signaling cascade drives the expression of pro-inflammatory genes and the secretion of cytokines such as TNF-α, IL-6, and IL-8, often through the activation of the NF-κB pathway.

Systemic symptoms and clinical implications

The transition from cellular damage to systemic symptoms occurs as these inflammatory mediators circulate and affect multiple organ systems.

• Neurological and systemic effects: Chronic exposure to these toxins is associated with symptoms such as headaches (sometimes characterized as toxic leukoencephalopathy), chronic fatigue, and fibromyalgia-like pain. These may result from systemic cytokines crossing the blood-brain barrier or inducing microglial activation.
• Gastrointestinal and immune impact: Acute exposure is known to cause gastrointestinal distress, including nausea and vomiting. Furthermore, these toxins can induce apoptosis (programmed cell death) in immune cells, potentially compromising immune surveillance.

Bottom line

Roridin A is scientifically confirmed to inhibit protein synthesis by damaging the 28S rRNA, which triggers a ribotoxic stress response. This response activates MAPK signaling and oxidative stress, leading to a pro-inflammatory state that mechanistically explains the systemic symptoms, such as fatigue and neurological distress, observed in exposed individuals.